VANCE DOLLY 4
4 · RIGEL PHARMACEUTICALS INC · Filed Mar 22, 2019
Insider Transaction Report
Form 4
VANCE DOLLY
SVP, Gen. Counsel, Corp. Sec.
Transactions
- Award
Employee Stock Option (right to buy)
2019-03-20+75,000→ 75,000 totalExercise: $4.49Exp: 2028-01-24→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]On January 24, 2018, the reporting person was granted a performance based option to purchase 75,000 shares of common stock based on a specific performance metric. On March 20, 2019, it was determined that the performance metric had been met.